January 25, 2022

Volume XII, Number 25

Advertisement

Elizabeth J. Haanes, Ph.D.

Dr. Haanes advises biotechnology companies on best practices for worldwide protection of their intellectual property.  She and her team are focused on formulating innovative long-term legal strategies which integrate seamlessly into her clients' technological and business objectives. She is an experienced counselor, advising on the creation and management of high-value patent portfolios, freedom-to-operate and patentability issues, validity and infringement issues, and due diligence investigations in connection with acquisitions and investments. She represents a diverse body of entities in technology areas such as vaccines, infectious diseases, medical diagnostics, biomarkers, personalized medicine, therapeutic antibodies, therapeutic nucleic acids, genomics, proteomics, and gene therapy.

Advertisement

Articles in the National Law Review database by Elizabeth J. Haanes, Ph.D.

Advertisement
Advertisement
Advertisement
Advertisement